Theravance Biopharma, Inc.
TBPH
Revenue
14.26M
▼-247.00k▼-1.70%
3 Months ChangeAssets
362.03M
▼-9.28M▼-2.50%
3 Months ChangeLiabilities
168.34M
▲1.90M▲1.14%
3 Months ChangeFree Cash Flow
-1.11M
▲11.05M▲90.85%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-23
Form 8-K
ID: 0001104659-24-101816
2024-09-10
Form 8-K
ID: 0001104659-24-098326
2024-08-08
Form 10-Q
ID: 0001558370-24-011636
2024-08-05
Form 8-K
ID: 0001104659-24-085826
2024-05-15
Form 10-Q
ID: 0001558370-24-008201
2024-05-13
Form 8-K
ID: 0001104659-24-060536
2024-05-09
Form 8-K
ID: 0001104659-24-059338
2024-02-28
Form 8-K
ID: 0001104659-24-028809
2024-02-26
Form 8-K
ID: 0001104659-24-027510
2024-01-16
Form 8-K
ID: 0001104659-24-003852